Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.
Clinical trial NCT02472964 · COMPLETED
Trial details
- NCT number
- NCT02472964
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.